Insulet | PODD - Current Liabilities



Insulet reported $1.01B in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Abbott USD 13.44B 435M Jun/2025
Align Technology USD 2B 4.54M Jun/2025
AtriCure USD 68.84M 7.62M Jun/2025
Avanos Medical USD 134.6M 2.6M Jun/2025
Baxter International USD 3.48B 3.03B Mar/2025
Becton, Dickinson and Co. USD 8.16B 469M Jun/2025
Boston Scientific USD 5.06B 1.34B Mar/2025
Cardinal Health USD 38.9B 2.24B Jun/2025
Cooper Companies USD 1.01B 2.4M Jul/2025
Dexcom USD 3.31B 271.6M Jun/2025
Edwards Lifesciences USD 1.39B 110.4M Mar/2025
Eli Lilly USD 39.02B 8.95B Jun/2025
Globus Medical USD 424.66M 39.96M Jun/2025
ICU Medical USD 482.78M 66.25M Jun/2025
Insulet USD 1.01B 489.7M Jun/2025
Integra LifeSciences USD 929.81M 11.35M Jun/2025
J&J USD 56.9B 6.58B Mar/2025
Masimo USD 592.1M 45.6M Jun/2025
Medtronic USD 12.88B 1.04B Apr/2025
Merit Medical Systems USD 225.57M 28.75M Jun/2025
Roche Holding CHF 27.02B 424M Dec/2024
Solventum Corp 2.62B 54M Jun/2025
Stryker USD 7.29B 641M Jun/2025
Tandem Diabetes Care USD 251.69M 36.48M Jun/2025
Teleflex USD 716.15M 40.24M Jun/2025
West Pharmaceutical Services USD 604.6M 77.9M Jun/2025
Zimmer Biomet Holdings USD 2.7B 404.6M Jun/2025